...
首页> 外文期刊>Bulletin of experimental biology and medicine >Bioluminescent Study of the Distribution of High-Molecular-Weight Protein Fraction of Cellex Daily Preparation in the Brain after Intranasal Administation
【24h】

Bioluminescent Study of the Distribution of High-Molecular-Weight Protein Fraction of Cellex Daily Preparation in the Brain after Intranasal Administation

机译:肿瘤内脑内脑内塞隆隆日制剂高分子量蛋白分数分布的生物发光研究

获取原文
获取原文并翻译 | 示例
           

摘要

Permeability of the blood-brain barrier for protein fractions 50-100 kDa (PF50-100) of Cellex Daily preparation labeled with fluorescent tracer FITC and non-conjugated FITC were compared after intranasal administration of the preparations to healthy rats. Fluorimetrical analysis of the serum and cerebrospinal fluid samples showed that Cellex Daily PF50-100-FITC administered intranasally penetrated into the blood and cerebrospinal fluid with maximum accumulation in 2 h after administration and persists in the circulation for 24 h probably due to binding with plasma proteins. The differences in the kinetic profile of PF50-100-FITC and free FITC indirectly suggest that the major part of the preparation is not degraded within 24 h and FITC is probably not cleaved from the protein components of the preparation. In vivo fluorescence analysis showed significant fluorescent signal in the olfactory bulbs in 6 h after intranasal administration; hence, the preparation administered via this route can bypass the blood-brain barrier. Scanning laser confocal microscopy of rat brain sections confirmed penetration of the high-molecular weight protein fraction PF50-100-FITC into CNS structures. The most pronounced accumulation of the labeled drug was observed in the olfactory bulb in 6 and 12 h after administration. In contrast to free FITC administered in the control group, significant accumulation of PF50-100-FITC in the olfactory cortex and frontal cortex neurons with functionally active nuclei was observed in 6, 12 and 24 h after intranasal administration.
机译:在鼻内施用对健康大鼠的制剂后,比较了用荧光示踪剂FITC和非共轭FITC标记的塞克隆日制剂的血脑屏障的渗透性50-100kDa(PF50-100)。血清和脑脊液样品的荧光分析表明,在给药后鼻内渗透到血液和脑脊液中,在给药后2小时的最大积聚渗透到血液和脑脊液中,并且可能由于与血浆蛋白质结合而持续存在24小时。 PF50-100-FITC和FITC的动力学分布的差异间接地表明制剂的主要部分在24小时内不会降解,并且FITC可能不会从制剂的蛋白质成分中切割。在体内荧光分析中,在鼻内给药后6小时内显示出嗅灯泡中的显着荧光信号;因此,通过该途径施用的制剂可以绕过血脑屏障。扫描大鼠脑切片的激光共焦显微镜切开证实了高分子量蛋白级分PF50-100-FITC的渗透到CNS结构。在给药后,在嗅球中观察到标记药物最明显的药物积聚。与对照组中施用的自由FITC相比,在鼻内给药后6,12和24小时观察到具有功能活性核的嗅觉核和额叶神经元中PF50-100-FITCC的显着积累。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号